CO5690553A2 - Procedimiento para la preparacion de sales de tiotropio, sales de tiotropio, asi como formulaciones medicamentosas que las contienen - Google Patents

Procedimiento para la preparacion de sales de tiotropio, sales de tiotropio, asi como formulaciones medicamentosas que las contienen

Info

Publication number
CO5690553A2
CO5690553A2 CO06041171A CO06041171A CO5690553A2 CO 5690553 A2 CO5690553 A2 CO 5690553A2 CO 06041171 A CO06041171 A CO 06041171A CO 06041171 A CO06041171 A CO 06041171A CO 5690553 A2 CO5690553 A2 CO 5690553A2
Authority
CO
Colombia
Prior art keywords
salts
kat
alkyl
procedure
preparation
Prior art date
Application number
CO06041171A
Other languages
English (en)
Inventor
Rolf Banholzer
Waldemar Pfrengle
Peter Sieger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530660&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5690553(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CO5690553A2 publication Critical patent/CO5690553A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1.- Procedimiento para la preparación de nuevas sales de tiotropio de la fórmula 1 en donde X- significa un anión, caracterizado porque una sal de tiotropio de la fórmula 2 en donde Y- significa un anión diferente a X- seleccionado del grupo constituido por halogenuro, alquil(C1-C10)sulfonato, alquil-(C1-C10)sulfato, aril(C6-C10)sulfonato, se hace reaccionar en un disolvente adecuado con una fuente de iones Kat-X, en la que Kat representa un catión y X puede tener los significados anteriormente citados.2.- Procedimiento conforme a la reivindicación 1, caracterizado porque como fuente de iones Kat-X se emplean los compuestos en los cuales el catión Kat se selecciona de la serie de los metales alcalinos o alcalinotérreos, o en los cuales Kat representa amonio(NH4) o también tetraalquilamonio (N(alquilo(C1-C8))4+, preferentemente N(alquilo(C1-C4))4+).3.- Procedimiento según la reivindicación 1 ó 2, caracterizado porque el disolvente se selecciona del grupo constituido por agua, alcoholes, amidas, éteres y nitrilos.4.- Procedimiento según la reivindicación 1, 2 ó 3, caracterizado porque el reactivo Kat-X se emplea en exceso referido al compuesto de partida de la fórmula 2 empleado.
CO06041171A 2003-11-03 2006-05-02 Procedimiento para la preparacion de sales de tiotropio, sales de tiotropio, asi como formulaciones medicamentosas que las contienen CO5690553A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03025075 2003-11-03

Publications (1)

Publication Number Publication Date
CO5690553A2 true CO5690553A2 (es) 2006-10-31

Family

ID=34530660

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06041171A CO5690553A2 (es) 2003-11-03 2006-05-02 Procedimiento para la preparacion de sales de tiotropio, sales de tiotropio, asi como formulaciones medicamentosas que las contienen

Country Status (35)

Country Link
US (1) US8686148B2 (es)
EP (3) EP1682541B1 (es)
JP (1) JP5165244B2 (es)
KR (1) KR20060117334A (es)
CN (3) CN101407514B (es)
AR (1) AR046317A1 (es)
AT (1) ATE460414T1 (es)
AU (1) AU2004285683C1 (es)
BR (1) BRPI0416136A (es)
CA (1) CA2544348A1 (es)
CO (1) CO5690553A2 (es)
CY (2) CY1110048T1 (es)
DE (1) DE502004010885D1 (es)
DK (2) DK2067779T3 (es)
EA (1) EA012326B1 (es)
ES (2) ES2342468T3 (es)
HK (3) HK1129111A1 (es)
HR (1) HRP20100149T1 (es)
IL (1) IL175023A (es)
ME (1) ME00361B (es)
MX (1) MXPA06004697A (es)
MY (1) MY143364A (es)
NO (1) NO335814B1 (es)
NZ (1) NZ547276A (es)
PE (1) PE20050446A1 (es)
PL (2) PL1682541T3 (es)
PT (2) PT1682541E (es)
RS (2) RS20060292A (es)
SG (1) SG137859A1 (es)
SI (2) SI2067779T1 (es)
TW (2) TWI435876B (es)
UA (1) UA82413C2 (es)
UY (1) UY28590A1 (es)
WO (1) WO2005042526A1 (es)
ZA (1) ZA200602342B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SG149876A1 (en) * 2003-11-03 2009-02-27 Boehringer Ingelheim Int Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
ES2396978T5 (es) * 2005-12-19 2015-12-04 Sicor, Inc. Forma cristalina novedosa de bromuro de tiotropio y procedimiento para la preparación de la misma
EA015353B1 (ru) * 2006-01-04 2011-06-30 Бёрингер Ингельхайм Интернациональ Гмбх Применение солей тиотропия для лечения персистирующей астмы средней тяжести
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
CZ201241A3 (cs) 2012-01-20 2013-07-31 Zentiva, K.S. Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
JP6042197B2 (ja) * 2012-12-11 2016-12-14 エア・ウォーター株式会社 肺障害治療剤

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2597329A (en) * 1947-08-06 1952-05-20 Merck & Co Inc Process for anion exchange of thiamin salts
US3551492A (en) * 1967-10-31 1970-12-29 Ciba Geigy Corp N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
JPS6165885A (ja) * 1984-09-07 1986-04-04 Tanabe Seiyaku Co Ltd 新規合成中間体及びその製法
US4811731A (en) 1985-07-30 1989-03-14 Glaxo Group Limited Devices for administering medicaments to patients
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP3302647B2 (ja) * 1992-04-24 2002-07-15 小野薬品工業株式会社 フェニルアルカン酸エステルの塩酸塩、およびその製造方法
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
JP4023086B2 (ja) 1999-12-27 2007-12-19 和光純薬工業株式会社 スルホニウム塩化合物
EP1430887A1 (de) 2000-10-12 2004-06-23 Boehringer Ingelheim Pharma GmbH & Co.KG Tiotropium-haltige Inhalationspulver
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
MEP40008A (en) * 2000-10-12 2011-02-10 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
CN101292964A (zh) * 2000-10-31 2008-10-29 贝林格尔英格海姆法玛两合公司 包含噻托铵盐溶液的可吸入制剂
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10061877A1 (de) 2000-12-12 2002-06-13 Basf Ag Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20020193394A1 (en) * 2001-03-13 2002-12-19 Bernd Disse Compounds for treating inflammatory diseases
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
GB0203193D0 (en) 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
US20030229227A1 (en) * 2002-03-16 2003-12-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
ES2272968T3 (es) 2002-04-04 2007-05-01 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO.KG Formulaciones en polvo, adecuadas para inhalacion.
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
DE10216036A1 (de) 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US6908055B2 (en) * 2003-02-27 2005-06-21 Tandberg Data Asa System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel
US20050030040A1 (en) * 2003-06-27 2005-02-10 Mitch Budniak Electrical testing device having voice annunciator
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SG149876A1 (en) 2003-11-03 2009-02-27 Boehringer Ingelheim Int Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
US8686148B2 (en) 2014-04-01
CY1114157T1 (el) 2016-08-31
EP2067779B9 (de) 2013-10-16
ZA200602342B (en) 2007-06-27
CN102070630B (zh) 2013-04-17
UY28590A1 (es) 2005-06-30
JP2007509893A (ja) 2007-04-19
ME00361B (me) 2011-10-10
CA2544348A1 (en) 2005-05-12
JP5165244B2 (ja) 2013-03-21
SI1682541T1 (sl) 2010-06-30
HRP20100149T1 (hr) 2010-04-30
CY1110048T1 (el) 2015-01-14
CN1882582A (zh) 2006-12-20
HK1153409A1 (en) 2012-03-30
CN102070630A (zh) 2011-05-25
RS51758B (en) 2011-12-31
TW200526653A (en) 2005-08-16
PL1682541T3 (pl) 2010-08-31
AU2004285683C1 (en) 2011-09-08
AU2004285683A1 (en) 2005-05-12
ES2342468T3 (es) 2010-07-07
AU2004285683B2 (en) 2011-04-21
ATE460414T1 (de) 2010-03-15
WO2005042526A1 (de) 2005-05-12
HK1129111A1 (en) 2009-11-20
DK1682541T3 (da) 2010-06-28
EP1682541B1 (de) 2010-03-10
IL175023A0 (en) 2006-08-20
TWI363758B (en) 2012-05-11
NO20061440L (no) 2006-07-12
NO335814B1 (no) 2015-02-23
EP2067779B1 (de) 2013-04-24
PL2067779T3 (pl) 2013-09-30
HK1099748A1 (en) 2007-08-24
IL175023A (en) 2011-02-28
TW201231465A (en) 2012-08-01
ES2422729T3 (es) 2013-09-13
CN101407514A (zh) 2009-04-15
UA82413C2 (uk) 2008-04-10
EP2336126A1 (de) 2011-06-22
RS20060292A (en) 2008-08-07
EP1682541A1 (de) 2006-07-26
BRPI0416136A (pt) 2007-01-02
PE20050446A1 (es) 2005-08-02
PT1682541E (pt) 2010-04-14
DK2067779T3 (da) 2013-07-29
US20050131007A1 (en) 2005-06-16
EA012326B1 (ru) 2009-08-28
MEP51308A (en) 2011-05-10
AR046317A1 (es) 2005-11-30
CN101407514B (zh) 2013-05-29
PT2067779E (pt) 2013-07-25
EP2067779A1 (de) 2009-06-10
SG137859A1 (en) 2007-12-28
TWI435876B (zh) 2014-05-01
CN100549010C (zh) 2009-10-14
NZ547276A (en) 2009-08-28
SI2067779T1 (sl) 2013-08-30
KR20060117334A (ko) 2006-11-16
EA200600886A1 (ru) 2006-10-27
MY143364A (en) 2011-04-29
DE502004010885D1 (de) 2010-04-22
MXPA06004697A (es) 2006-07-05

Similar Documents

Publication Publication Date Title
CO5690553A2 (es) Procedimiento para la preparacion de sales de tiotropio, sales de tiotropio, asi como formulaciones medicamentosas que las contienen
JP2017222882A5 (es)
CO5690554A2 (es) Nuevas sales de tiotropio, procedimientos para su preparacion asi como formulaciones medicamentosas que las contienen
AR046322A1 (es) Compuestos de amidoacetonitrilo, metodos para su preparacion y de sus intermediarios y su uso en composiciones antiparasitarias.
BRPI0719473B8 (pt) Método para a preparação de um composto
BR0308126A (pt) Composto de fosfonamida, processo para produzir o mesmo, agente e processo para extrair um ìon de metal de terra rara, e, processo para retro-extrair um ìon de metal de terra rara
BRPI0511500A (pt) processo para a preparação de um composto de amÈnio quaternário, uso de uma solução de hidróxido de tetrametilamÈnio de alta pureza, e solução aquosa de hidróxido de tetrametilamÈnio de alta pureza
RU2008127541A (ru) Новые соли
AR060690A1 (es) Polimeros que contienen magnesio para la hiperfosfatemia
DE3786896T2 (de) Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen.
AR044883A1 (es) Derivados del 8-aza-biciclo [3.2.1] octano y su uso como inhibidores de la recaptacion de neurotransmisores monoaminicos
MX2022000996A (es) Nuevo glucosido de esteviol, metodo para su produccion y composicion endulzante que contiene al mismo.
RU2002128631A (ru) Стабилизированные жидкие препаративные формы
KR970703342A (ko) 아자비시클릭 유도체의 제조 방법(Process for The Preparation of Azabicyclic Derivatives)
BR112022014308A2 (pt) Processo químico para a preparação de compostos herbicidas de piridazina
ES2264374A1 (es) Procedimiento de fabricacion de la metilcobalamina.
AR058210A1 (es) Procedimiento para preparar 5-amino-3h-tiazolo[4,5-d]pirimidin-2-ona, un intermediario util para la preparacion de ciertos nucleosidos de tiazolo[4,5-d]pirimidina que actuan como inmunomoduladores.
BR112022017684A2 (pt) Composição de limpeza
BRPI0517302A (pt) processo de preparação de compostos de pirimidina
RU2003131897A (ru) Соединения фосфония фосфината и их получения
GB1064900A (en) Basic ethers and preparation thereof
JPWO2021111919A5 (es)
RU2005100690A (ru) Композиционный противостаритель для резин
AR034260A1 (es) Proceso catalitico para la preparacion de derivados de tiazol
ES2114231T3 (es) Procedimiento para la produccion de una sal de adicion de acido del isomero z de un compuesto de trifeniletileno.

Legal Events

Date Code Title Description
FC Application refused
FD Application lapsed